Offer - Urjas Oil for just ₹ 1 X
Tidomet LS Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tidomet LS Tablet (10) safe for pregnant women?
Tidomet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Tidomet right away. Take your doctor's advice before taking it again.
Is the use of Tidomet LS Tablet (10) safe during breastfeeding?
Breastfeeding women can take Tidomet as it bears very minor side effects for them.
What is the effect of Tidomet LS Tablet (10) on the Kidneys?
Tidomet has very mild side effects on the kidneys.
What is the effect of Tidomet LS Tablet (10) on the Liver?
Side effects of Tidomet rarely affect the liver.
What is the effect of Tidomet LS Tablet (10) on the Heart?
Side effects of Tidomet rarely affect the heart.
Tidomet LS Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tidomet LS Tablet (10) unless your doctor advises you to do so -
Is this Tidomet LS Tablet (10) habit forming or addictive?
Yes, you can get addicted to Tidomet LS Tablet (10). It is essential that you take [medicine] only after doctor's recommendation.
Interaction between Food and Tidomet LS Tablet (10)
When consumed with certain foods, Tidomet LS Tablet (10) may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tidomet LS Tablet (10)
Consult your doctor before consuming alcohol while taking Tidomet LS Tablet (10) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 426-429
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 54-55
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 279-281
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 429-430
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lodosyn® (carbidopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sinemet® (carbidopa-levodopa)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rytary® (carbidopa-levodopa)